Literature DB >> 16430743

The efficacy of amlexanox OraDisc on the prevention of recurrent minor aphthous ulceration.

B Murray1, P A Biagioni, P-J Lamey.   

Abstract

BACKGROUND: The study was designed to determine the efficacy of OraDisc (active component 2 mg amlexanox) on the prevention of aphthous ulcers treated at the prodromal stage.
METHODS: Thermographic imaging was used to confirm the presence of a prodromal ulcer. Fifty-two patients were randomized to receive OraDisc (N = 26) or vehicle patches (N = 26). Patches were applied four times a day for 72 h over the prodromal area. The percentage of subjects who developed an ulcer at 72 h was compared between groups using the Fisher's exact test.
RESULTS: About 50% of subjects in the OraDisc group developed an ulcer by day 4 compared with 69% in the vehicle group. Erythema score, ulcer size, pain scores and thermographically active area and temperature all showed trends towards healing in the OraDisc group.
CONCLUSION: The OraDisc prevents ulcers from developing when compared with the vehicle patch.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430743     DOI: 10.1111/j.1600-0714.2006.00379.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  9 in total

Review 1.  Urban legends: recurrent aphthous stomatitis.

Authors:  L Baccaglini; R V Lalla; A J Bruce; J C Sartori-Valinotti; M C Latortue; M Carrozzo; R S Rogers
Journal:  Oral Dis       Date:  2011-08-04       Impact factor: 3.511

Review 2.  The treatment of chronic recurrent oral aphthous ulcers.

Authors:  Andreas Altenburg; Nadine El-Haj; Christiana Micheli; Marion Puttkammer; Mohammed Badawy Abdel-Naser; Christos C Zouboulis
Journal:  Dtsch Arztebl Int       Date:  2014-10-03       Impact factor: 5.594

3.  Critical Role of Cytosolic DNA and Its Sensing Adaptor STING in Aortic Degeneration, Dissection, and Rupture.

Authors:  Wei Luo; Yidan Wang; Lin Zhang; Pingping Ren; Chen Zhang; Yanming Li; Alon R Azares; Michelle Zhang; Jiao Guo; Ketan B Ghaghada; Zbigniew A Starosolski; Kimal Rajapakshe; Cristian Coarfa; Yumei Li; Rui Chen; Keigi Fujiwara; Jun-Ichi Abe; Joseph S Coselli; Dianna M Milewicz; Scott A LeMaire; Ying H Shen
Journal:  Circulation       Date:  2019-12-30       Impact factor: 29.690

4.  Effectiveness of Amlexanox and Adcortyl for the treatment of recurrent aphthous ulcers.

Authors:  Farid Abbasi; Maryam Raoof; Roya Khatami; Niloofar Shadman; Farnaz Borjian-Boroojeni; Farahnaz Nazari
Journal:  J Clin Exp Dent       Date:  2016-10-01

Review 5.  Evolution of Drug Delivery Systems for Recurrent Aphthous Stomatitis.

Authors:  Ine Suharyani; Ahmed Fouad Abdelwahab Mohammed; Muchtaridi Muchtaridi; Nasrul Wathoni; Marline Abdassah
Journal:  Drug Des Devel Ther       Date:  2021-09-27       Impact factor: 4.162

6.  A new approach to the treatment of recurrent aphthous stomatitis with bioadhesive gels containing cyclosporine A solid lipid nanoparticles: in vivo/in vitro examinations.

Authors:  Sinem Yaprak Karavana; Evren Homan Gökçe; Seda Rençber; Seda Özbal; Cetin Pekçetin; Pelin Güneri; Gökhan Ertan
Journal:  Int J Nanomedicine       Date:  2012-11-09

7.  A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial.

Authors:  Wenxia Meng; Yi Dong; Jie Liu; Zhi Wang; Xiaobo Zhong; Ruiyang Chen; Hongmei Zhou; Mei Lin; Lu Jiang; Feng Gao; Tao Xu; Qianming Chen; Xin Zeng
Journal:  Trials       Date:  2009-05-06       Impact factor: 2.279

8.  Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis: A Randomized Controlled Trial.

Authors:  Katayoun Borhan-Mojabi; Faezeh Mirmiran; Marjan Nassiri-Asl; Pantea Nazeman; Hassan Jahanihashemi
Journal:  J Dent (Tehran)       Date:  2014-03-31

9.  Quality of life in patients with recurrent aphthous stomatitis treated with a mucoadhesive patch containing citrus essential oil.

Authors:  Esma Kürklü-Gürleyen; Merve Öğüt-Erişen; Onur Çakır; Ömer Uysal; Gülsüm Ak
Journal:  Patient Prefer Adherence       Date:  2016-05-27       Impact factor: 2.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.